{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T14:07:07Z","timestamp":1792850827200,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016005","name":"Yulgilbar Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.parkreldis.2020.09.030","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T17:38:43Z","timestamp":1600882723000},"page":"184-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Prevalence and clinical associations of tau in Lewy body dementias: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"80","author":[{"given":"Kai Sin","family":"Chin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawaf","family":"Yassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid","family":"Churilov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin Louis","family":"Masters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosie","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.parkreldis.2020.09.030_bib1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2020.09.030_bib2","doi-asserted-by":"crossref","first-page":"214 e7","DOI":"10.1016\/j.neurobiolaging.2015.10.028","article-title":"Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases","volume":"38","author":"Guerreiro","year":"2016","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.parkreldis.2020.09.030_bib3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jagp.2013.03.001","article-title":"Amyloid PET imaging in lewy body disorders","volume":"23","author":"Donaghy","year":"2015","journal-title":"Am. J. Geriatr. Psychiatr."},{"issue":"8","key":"10.1016\/j.parkreldis.2020.09.030_bib4","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/mds.26668","article-title":"Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia","volume":"31","author":"Abdelnour","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2020.09.030_bib5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.arr.2017.03.002","article-title":"Vivio tau PET imaging in dementia: pathophysiology, radiotracer quantification, and a systematic review of clinical findings","volume":"36","author":"Hall","year":"2017","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.parkreldis.2020.09.030_bib6","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2011"},{"issue":"3","key":"10.1016\/j.parkreldis.2020.09.030_bib7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s007020200027","article-title":"Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease","volume":"109","author":"Jellinger","year":"2002","journal-title":"J. Neural. Transm."},{"issue":"10","key":"10.1016\/j.parkreldis.2020.09.030_bib8","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/01.WNL.0000065889.42856.F2","article-title":"Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies","volume":"60","author":"Merdes","year":"2003","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.parkreldis.2020.09.030_bib9","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1176\/appi.ajp.161.5.843","article-title":"Neuropathological substrates of psychiatric symptoms in prospectively studies patients with autopsy-confirmed dementia with Lewy bodies","volume":"161","author":"Ballard","year":"2004","journal-title":"Am. J. Psychiatr."},{"issue":"5","key":"10.1016\/j.parkreldis.2020.09.030_bib10","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/ana.20635","article-title":"Neuropathology of dementia in Parkinson's disease: a prospective, community-based study","volume":"58","author":"Aarsland","year":"2005","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.parkreldis.2020.09.030_bib11","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1212\/01.WNL.0000158422.41380.82","article-title":"Cognitive status correlates with neuropathologic stage in Parkinson disease","volume":"64","author":"Braak","year":"2005","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.parkreldis.2020.09.030_bib12","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1212\/01.wnl.0000180964.60708.c2","article-title":"Verbal and visuospatial deficits in dementia with Lewy bodies","volume":"65","author":"Johnson","year":"2005","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.parkreldis.2020.09.030_bib13","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1212\/01.wnl.0000249130.63615.cc","article-title":"Differences in neuropathologic characteristics across the Lewy body dementia spectrum","volume":"67","author":"Ballard","year":"2006","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.parkreldis.2020.09.030_bib14","first-page":"356","article-title":"Dementia with Lewy bodies","volume":"69","author":"Weisman","year":"2007","journal-title":"Braak stage determines phenotype, not Lewy body distribution Neurology"},{"issue":"6","key":"10.1016\/j.parkreldis.2020.09.030_bib15","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1037\/a0012949","article-title":"Visuospatial deficits predict rate of cognitive decline in autopsy0verified dementia with Lewy bodies","volume":"22","author":"Hamilton","year":"2008","journal-title":"Neuropsychology"},{"issue":"4","key":"10.1016\/j.parkreldis.2020.09.030_bib16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00401-008-0347-5","article-title":"Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease","volume":"115","author":"Jellinger","year":"2008","journal-title":"Acta Neuropathol."},{"issue":"14","key":"10.1016\/j.parkreldis.2020.09.030_bib17","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1212\/WNL.0b013e3181bacf9e","article-title":"Relative preservation of MMSE scores in autopsy-proven dementia with Lewy bodies","volume":"73","author":"Nelson","year":"2009","journal-title":"Neurology"},{"issue":"Pt 5","key":"10.1016\/j.parkreldis.2020.09.030_bib18","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/brain\/awr031","article-title":"Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?","volume":"134","author":"Compta","year":"2011","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.parkreldis.2020.09.030_bib19","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/mds.24003","article-title":"Rapid eye movement sleep behavior disorder and subtypes in autopsy-confirmed dementia with Lewy bodies","volume":"27","author":"Dugger","year":"2012","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.parkreldis.2020.09.030_bib20","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/ana.23659","article-title":"Neuropathologic substrates of Parkinson disease dementia","volume":"72","author":"Irwin","year":"2012","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.parkreldis.2020.09.030_bib21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.parkreldis.2012.10.013","article-title":"Pathology and temporal onset of visual hallucinations, misperceptions and family misidentification distinguishes dementia with Lewy bodies from Alzheimer's disease","volume":"19","author":"Ferman","year":"2013","journal-title":"Park. Relat. Disord."},{"issue":"19","key":"10.1016\/j.parkreldis.2020.09.030_bib22","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1212\/01.wnl.0000435299.57153.f0","article-title":"MRI and pathology of REM sleep behavior disorder in dementia with Lewy bodies","volume":"81","author":"Murray","year":"2013","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.parkreldis.2020.09.030_bib23","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1136\/jnnp-2012-304381","article-title":"Early neuropsychological discriminants for Lewy body disease: an autopsy series","volume":"84","author":"Yoshizawa","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"issue":"1","key":"10.1016\/j.parkreldis.2020.09.030_bib24","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.neurobiolaging.2014.07.005","article-title":"Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies","volume":"36","author":"Nedelska","year":"2015","journal-title":"Neurobiol. Aging"},{"issue":"6","key":"10.1016\/j.parkreldis.2020.09.030_bib25","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1017\/S1355617716000436","article-title":"Visual perceptual organization ability in autopsy-verified dementia with lewy bodies and alzheimer's disease","volume":"22","author":"Mitolo","year":"2016","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.parkreldis.2020.09.030_bib26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.parkreldis.2016.07.008","article-title":"Phenotypic differences based on staging of Alzheimer's neuropathology in autopsy-confirmed dementia with Lewy bodies","volume":"31","author":"Peavy","year":"2016","journal-title":"Park. Relat. Disord."},{"issue":"5","key":"10.1016\/j.parkreldis.2020.09.030_bib27","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/nan.12294","article-title":"Cortical Lewy bodies and Abeta burden are associated with prevalence and timing of dementia in Lewy body diseases","volume":"42","author":"Ruffmann","year":"2016","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"3","key":"10.1016\/j.parkreldis.2020.09.030_bib28","first-page":"216","article-title":"Regional overlap of pathologies in lewy body disorders","volume":"76","author":"Colom-Cadena","year":"2017","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"3","key":"10.1016\/j.parkreldis.2020.09.030_bib29","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1001\/jamaneurol.2016.4926","article-title":"Duration and pathologic correlates of lewy body disease","volume":"74","author":"Graff-Radford","year":"2017","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.parkreldis.2020.09.030_bib30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/ana.25392","article-title":"Cognitive and pathological influences of tau pathology in lewy body disorders","volume":"85","author":"Coughlin","year":"2019","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.parkreldis.2020.09.030_bib31","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/gps.5080","article-title":"Associations among Braak stage, Parkinsonian gait, cognition, and functional status in autopsy-confirmed dementia with Lewy bodies","volume":"34","author":"Mayo","year":"2019","journal-title":"Int. J. Geriatr. Psychiatr."},{"issue":"5","key":"10.1016\/j.parkreldis.2020.09.030_bib32","doi-asserted-by":"crossref","first-page":"e476","DOI":"10.1212\/WNL.0000000000007855","article-title":"Neuropathologic correlates of amyloid and dopamine transporter imaging in Lewy body disease","volume":"93","author":"Shirvan","year":"2019","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.parkreldis.2020.09.030_bib33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.parkreldis.2020.09.030_bib34","first-page":"479","article-title":"The Consortium to establish a Registry for alzheimer's disease (CERAD). Part II","volume":"41","author":"Mirra","year":"1991","journal-title":"Standardization of the neuropathologic assessment of Alzheimer's disease, Neurology"},{"issue":"4 Suppl","key":"10.1016\/j.parkreldis.2020.09.030_bib35","first-page":"S1","article-title":"Consensus recommendations for the postmortem diagnosis of alzheimer's disease. The national Institute on aging, and Reagan Institute working Group on diagnostic criteria for the neuropathological assessment of alzheimer's disease","volume":"18","year":"1997","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.parkreldis.2020.09.030_bib36","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.neuint.2005.11.002","article-title":"Neuropsychological and behavioural correlates of CSF biomarkers in dementia","volume":"48","author":"Engelborghs","year":"2006","journal-title":"Neurochem. Int."},{"issue":"3","key":"10.1016\/j.parkreldis.2020.09.030_bib37","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000094871","article-title":"Beta-amyloid 1-42 and tau protein in cerebrospinal fluid of patients with Parkinson's disease dementia","volume":"22","author":"Mollenhaur","year":"2006","journal-title":"Dement. Geriatr. Cognit. Disord."},{"issue":"10","key":"10.1016\/j.parkreldis.2020.09.030_bib38","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.biopsych.2008.02.016","article-title":"Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies","volume":"64","author":"Parnetti","year":"2008","journal-title":"Biol. Psychiatr."},{"issue":"15","key":"10.1016\/j.parkreldis.2020.09.030_bib39","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1002\/mds.22594","article-title":"Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease","volume":"24","author":"Compta","year":"2009","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2020.09.030_bib40","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3233\/JAD-2010-100186","article-title":"CSF alpha-synuclein does not discriminate dementia with Lewy bodies from Alzheimer's disease","volume":"22","author":"Reesink","year":"2010","journal-title":"J Alzheimers Dis"},{"issue":"12","key":"10.1016\/j.parkreldis.2020.09.030_bib41","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1212\/WNL.0b013e3181f39a78","article-title":"CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease","volume":"75","author":"Siderowf","year":"2010","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.parkreldis.2020.09.030_bib42","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/gps.2496","article-title":"The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia","volume":"26","author":"Andersson","year":"2011","journal-title":"Int. J. Geriatr. Psychiatr."},{"issue":"1","key":"10.1016\/j.parkreldis.2020.09.030_bib43","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1212\/WNL.0b013e31823ed0f0","article-title":"Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort","volume":"78","author":"Schoonenboom","year":"2012","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.parkreldis.2020.09.030_bib44","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/gps.3881","article-title":"Correlations of CSF tau and amyloid levels with Alzheimer pathology in neuropathologically verified dementia with Lewy bodies","volume":"28","author":"Brunnstrom","year":"2013","journal-title":"Int. J. Geriatr. Psychiatr."},{"issue":"Pt 9","key":"10.1016\/j.parkreldis.2020.09.030_bib45","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1093\/brain\/awv181","article-title":"Cerebrospinal fluid tau and amyloid-beta1-42 in patients with dementia","volume":"138","author":"Skillback","year":"2015","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.parkreldis.2020.09.030_bib46","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3233\/JAD-160322","article-title":"Cerebrospinal fluid alzheimer's disease biomarkers across the spectrum of lewy body diseases: results from a large multicenter cohort","volume":"54","author":"van Steenoven","year":"2016","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"10.1016\/j.parkreldis.2020.09.030_bib47","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/jnnp-2016-313775","article-title":"Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies","volume":"88","author":"Lemstra","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2020.09.030_bib48","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jns.2016.12.064","article-title":"Cross-sectional and longitudinal associations of motor fluctuations and non-motor predominance with cerebrospinal tau and Abeta as well as dementia-risk in Parkinson's disease","volume":"373","author":"Modreanu","year":"2017","journal-title":"J. Neurol. Sci."},{"issue":"10","key":"10.1016\/j.parkreldis.2020.09.030_bib49","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1007\/s00415-018-8992-7","article-title":"Neuropsychiatric symptoms and alpha-Synuclein profile of patients with Parkinson's disease dementia, dementia with Lewy bodies and Alzheimer's disease","volume":"265","author":"Bougea","year":"2018","journal-title":"J. Neurol."},{"issue":"5","key":"10.1016\/j.parkreldis.2020.09.030_bib50","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/jnnp-2017-316385","article-title":"Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer's disease at the prodromal stage","volume":"89","author":"Bousiges","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4\u20136","key":"10.1016\/j.parkreldis.2020.09.030_bib51","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000500567","article-title":"In vivo prevalence of alzheimer biomarkers in dementia with lewy bodies","volume":"47","author":"Paraskevas","year":"2019","journal-title":"Dement. Geriatr. Cognit. Disord."},{"issue":"11","key":"10.1016\/j.parkreldis.2020.09.030_bib52","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1001\/jamaneurol.2016.3338","article-title":"Tau positron emission tomographic imaging in the lewy body diseases","volume":"73","author":"Gomperts","year":"2016","journal-title":"JAMA Neurol"},{"issue":"6","key":"10.1016\/j.parkreldis.2020.09.030_bib53","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/mds.26961","article-title":"Vivo cortical tau in Parkinson's disease using 18F-AV-1451 positron emission tomography","volume":"32","author":"Hansen","year":"2017","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2020.09.030_bib54","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ana.24825","article-title":"AV-1451 tau and beta-amyloid positron emission tomography imaging in dementia with Lewy bodies","volume":"81","author":"Kantarci","year":"2017","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.parkreldis.2020.09.030_bib55","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/mds.27252","article-title":"Distinct patterns of amyloid-dependent tau accumulation in Lewy body diseases","volume":"33","author":"Lee","year":"2018","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.parkreldis.2020.09.030_bib56","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1093\/brain\/awz268","article-title":"The bivariate distribution of amyloid-beta and tau: relationship with established neurocognitive clinical syndromes","volume":"142","author":"Jack","year":"2019","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.parkreldis.2020.09.030_bib57","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/mds.27603","article-title":"F-AV-1451 uptake differs between dementia with lewy bodies and posterior cortical atrophy","volume":"34","author":"Nedelska","year":"2019","journal-title":"Mov. Disord."},{"issue":"Pt 11","key":"10.1016\/j.parkreldis.2020.09.030_bib58","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/brain\/awl269","article-title":"CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease","volume":"129","author":"Buerger","year":"2006","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.parkreldis.2020.09.030_bib59","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/ana.24517","article-title":"Validating novel tau PET tracer [f-18]-AV-1451 (T807) on postmortem brain tissue","volume":"78","author":"Marquie","year":"2015","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.parkreldis.2020.09.030_bib60","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s40336-018-0290-y","article-title":"The development and validation of tau PET tracers: current status and future directions","volume":"6","author":"Okamura","year":"2018","journal-title":"Clin Transl Imaging"},{"issue":"5","key":"10.1016\/j.parkreldis.2020.09.030_bib61","doi-asserted-by":"crossref","first-page":"633","DOI":"10.4088\/JCP.v66n0514","article-title":"Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias","volume":"66","author":"Aarsland","year":"2005","journal-title":"J. Clin. Psychiatr."},{"issue":"11","key":"10.1016\/j.parkreldis.2020.09.030_bib62","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1017\/S1041610213001245","article-title":"Montreal Cognitive Assessment and Mini-Mental State Examination performance in patients with mild-to-moderate dementia with Lewy bodies, Alzheimer's disease, and normal participants in Taiwan","volume":"25","author":"Wang","year":"2013","journal-title":"Int. Psychogeriatr."},{"issue":"8","key":"10.1016\/j.parkreldis.2020.09.030_bib63","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1177\/1533317517725811","article-title":"Utility of montreal cognitive assessment in differentiating dementia with lewy bodies from Alzheimer's dementia","volume":"32","author":"Yamamoto","year":"2017","journal-title":"Am. J. Alzheimer's Dis. Other Dementias"},{"issue":"4","key":"10.1016\/j.parkreldis.2020.09.030_bib64","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00702-016-1517-6","article-title":"MMSE and MoCA in Parkinson's disease and dementia with Lewy bodies: a multicenter 1-year follow-up study","volume":"123","author":"Biundo","year":"2016","journal-title":"J. Neural. Transm."},{"issue":"1","key":"10.1016\/j.parkreldis.2020.09.030_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging\u2013Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach","volume":"123","author":"Montine","year":"2011","journal-title":"Acta Neuropathol."}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802020307604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802020307604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:21:04Z","timestamp":1761178864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802020307604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":65,"alternative-id":["S1353802020307604"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2020.09.030","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and clinical associations of tau in Lewy body dementias: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2020.09.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}